Results 11 to 20 of about 5,155,633 (254)
Are Vaccines Effective in Preventing Variant COVID 19 Disease? A Case of Vaccinated Variant COVID 19
COVID 19 disease caused by the SARS-CoV-2 virus is the most important public health problem of today. The pandemic caused by this virus has radically changed the way of life all over the world. Vaccines developed against this virus are our most important
Bahadır Ertürk +2 more
doaj +1 more source
COVID-19 Booster Vaccines Administration in Different Countries
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in the COVID-19 global pandemic had consequently led to the development of different types of COVID-19 vaccines, including the messenger RNA (mRNA) vaccines, inactivated virus
Angel Yun-Kuan Thye +3 more
doaj +1 more source
The Time for COVID-19 Vaccination
The composition and dynamics of viral mutant spectra in infected individuals advise that to avoid selection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape mutants, vaccination campaigns for coronavirus disease 2019 (COVID-19) should be launched when disease incidence is low.
Domingo, Esteban, Perales, Celia
openaire +4 more sources
COVID‐19: vaccine’s progress [PDF]
Summary Under the pressure of the COVID‐19 pandemic, vaccines were developed and rolled out into mass vaccination campaigns at incredible speed. What normally takes a decade was worked out within a year. Vaccines were produced along many different platforms ranging from inactivated whole virus vaccines over adenovirus‐vectored ...
openaire +4 more sources
Mandating COVID-19 Vaccines [PDF]
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines hold promise to control the pandemic, and help restore normal social and economic life. The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for 2 mRNA vaccines and will likely issue full biologics licenses in the coming months.
Gostin, Lawrence O. +2 more
openaire +3 more sources
Dermatological Complications of COVID 19 Vaccines: An Updated Review
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the 2019 coronavirus disease (COVID-19) pandemic, have been rapidly developed and authorized.
Mohammed Omar Alsadi, Vinita John
doaj +1 more source
As of 2022, the global population has access to several mRNA and traditional inactivated vaccines. However, their effectiveness in preventing infection, hospitalization, and COVID-associated mortality in Jordan has yet to be evaluated. The purpose of this observational study was to evaluate the relative effectiveness of three approved vaccines against ...
Mohamed J. Saadh, Saif Aldeen Jaber
openaire +2 more sources
Vaccination is the most effective intervention to prevent infection and subsequent complications from SARS-CoV-2. Because of their multiple comorbidities, the elderly population experienced the highest number of deaths from the COVID-19 pandemic ...
Chia-Yu Huang +8 more
doaj +1 more source
Safety of COVID‐19 vaccines [PDF]
AbstractThis study is aimed to identify the adverse effects associated with three types of coronavirus disease 2019 vaccines. Approximately 1736 individuals agreed to participate in this study. The participants involved in the study were individuals who had received the first dose or full course (two doses) of the vaccine at least 30 days before the ...
Qutaiba A. Al Khames Aga +9 more
openaire +2 more sources
How can COVID-19 vaccines benefit people? A study based on the theory of the commons
COVID−19 vaccination is a fundamental step toward controlling the COVID−19 pandemic and defusing the public health crisis it has caused. Existing studies have demonstrated that equitable distribution of COVID−19 vaccines can only be achieved if these ...
Yiqing Su +3 more
doaj +1 more source

